Clincosm LogoSign in Get a demo

Diabetes Mellitus, Type 1

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in United States (Glucagon)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Stanford, California
  • +6 more
Nov 16, 2018

Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Montgomery, Alabama
  • +188 more
Oct 31, 2018

Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 1
  • inhaled human insulin
  • +2 more
  • Birmingham, Alabama
  • +95 more
Sep 3, 2018

Diabetes, Type 1 Trial in United States (Nasal Glucagon, Intramuscular Glucagon)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Nasal Glucagon
  • Intramuscular Glucagon
  • Aurora, Colorado
  • +6 more
Aug 1, 2018

Diabetes, Type 1 Trial in United States (Placebo, PF-06342674 Dose A, PF-06342674 Dose B)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Placebo
  • +4 more
  • San Diego, California
  • +20 more
Oct 27, 2017

Diabetes, Type 1 Trial in United States (HDV insulin lispro 100 UNT/ML, Insulin Lispro 100 UNT/ML)

Completed
  • Diabetes Mellitus, Type 1
  • HDV insulin lispro 100 UNT/ML
  • Insulin Lispro 100 UNT/ML
  • Aurora, Colorado
  • +4 more
Jul 29, 2018

Diabetes, Type 1 Trial in United States (Aralast NP 45 mg dose, Aralast NP 90 mg dose, Aralast NP 180 mg dose)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Aralast NP 45 mg dose
  • +2 more
  • San Diego, California
  • +14 more
May 14, 2018

Diabetes, Type 1 Trial in United States (Accu-Chek® CONNECT DMS, DMS)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Accu-Chek® CONNECT DMS
  • DMS
  • Phoenix, Arizona
  • +12 more
Apr 19, 2018

Diabetes, Type 1 Trial in Worldwide (Artificial Pancreas)

Completed
  • Diabetes Mellitus, Type 1
  • Artificial Pancreas
  • Santa Barbara, California
  • +9 more
May 1, 2018

Diabetes, Type 1 Trial in Worldwide (Glargine, LY2605541, Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Concord, California
  • +50 more
Mar 16, 2018

Diabetes, Type 1 Trial in Worldwide (Glargine, LY2605541, Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Concord, California
  • +118 more
Mar 16, 2018

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in United Kingdom, United States (FlorenceM, Medtronic insulin

Completed
  • Diabetes Mellitus
  • +4 more
  • FlorenceM
  • Medtronic insulin pump 640G
  • Aurora, Colorado
  • +7 more
Mar 12, 2018

Diabetes, Type 1 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 1
  • Human Insulin Inhalation Powder
  • +2 more
  • Aurora, Colorado
  • +36 more
Mar 7, 2018

Diabetes, Type 1 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable Insulin, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 1
  • Human Insulin Inhalation Powder
  • +2 more
  • Sacramento, California
  • +60 more
Mar 7, 2018

Diabetes, Type 1 Trial in United States (Predictive Low Glucose Suspend)

Completed
  • Diabetes Mellitus, Type 1
  • Predictive Low Glucose Suspend
  • Palo Alto, California
  • +3 more
Feb 7, 2018

Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Birmingham, Alabama
  • +16 more
Oct 11, 2017

Diabetes, Type 1 Trial in Worldwide (otelixizumab infusion plus physician determined standard of care, infusion plus physician

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • otelixizumab infusion plus physician determined standard of care
  • placebo infusion plus physician determined standard of care
  • Birmingham, Alabama
  • +108 more
Sep 5, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +90 more
Mar 8, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)

Completed
Has Results
  • Diabetes
  • +3 more
  • FlexTouch®
  • FlexPen®
  • Burlingame, California
  • +64 more
Feb 6, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin detemir, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec/insulin aspart
  • +2 more
  • La Mesa, California
  • +80 more
Feb 9, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Encino, California
  • +81 more
Dec 16, 2016

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Phoenix, Arizona
  • +119 more
Dec 15, 2016

Diabetes, Type 1 Trial in United States (Aralast NP, Placebo)

Withdrawn
  • Diabetes Mellitus, Type 1
  • Aralast NP
  • Placebo
  • La Jolla, California
  • +14 more
Dec 30, 2014

Diabetes, Type 1 Trial in United States (Insulin Lispro, regular human insulin, recombinant human hyaluronidase PH20)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Lispro
  • +3 more
  • Aurora, Colorado
  • +7 more
Aug 28, 2014

Diabetes, Type 1, Hyperlipidemias Trial in Aurora (Colesevelam HCl, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • Hyperlipidemias
  • Colesevelam HCl
  • Placebo
  • Aurora, Colorado
    Barbara Davis Center for Diabetes
May 19, 2014